Trial · NCT01419795
Adverse events14
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 14 of 14
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Superior vena cava obstruction | Vascular disorders | Arm I (Lenalidomide, Rituximab) | 1 | 3 | 1 |
| serious | Superior vena cava obstruction | Vascular disorders | Arm II (Lenalidomide) | 0 | 0 | 0 |
| serious | Hyperglycemia | Metabolism and nutrition disorders | Arm I (Lenalidomide, Rituximab) | 1 | 3 | 1 |
| serious | Hyperglycemia | Metabolism and nutrition disorders | Arm II (Lenalidomide) | 0 | 0 | 0 |
| serious | Dehydration | Metabolism and nutrition disorders | Arm I (Lenalidomide, Rituximab) | 1 | 3 | 1 |
| serious | Dehydration | Metabolism and nutrition disorders | Arm II (Lenalidomide) | 0 | 0 | 0 |
| serious | Tumor flare syndrome | Metabolism and nutrition disorders | Arm I (Lenalidomide, Rituximab) | 1 | 3 | 1 |
| serious | Tumor flare syndrome | Metabolism and nutrition disorders | Arm II (Lenalidomide) | 0 | 0 | 0 |
| serious | Dyspnea | Respiratory, thoracic and mediastinal disorders | Arm I (Lenalidomide, Rituximab) | 1 | 3 | 1 |
| serious | Dyspnea | Respiratory, thoracic and mediastinal disorders | Arm II (Lenalidomide) | 0 | 0 | 0 |
| serious | Neutropenia | Blood and lymphatic system disorders | Arm I (Lenalidomide, Rituximab) | 1 | 3 | 1 |
| serious | Neutropenia | Blood and lymphatic system disorders | Arm II (Lenalidomide) | 0 | 0 | 0 |
| serious | Rash >50% BSA | Skin and subcutaneous tissue disorders | Arm I (Lenalidomide, Rituximab) | 1 | 3 | 1 |
| serious | Rash >50% BSA | Skin and subcutaneous tissue disorders | Arm II (Lenalidomide) | 0 | 0 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01419795/events